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ABSTRACT
A well-designed implementation of medication concepts, records, and lists in
an electronic medical record (EMR) system allows it to successfully perform
many functions vital for the provision of quality health care. A controlled
medication terminology provides the foundation for decision support services,
such as duplication checking, allergy checking, and drug-drug interaction
alerts. Clever modeling of medication records makes it easy to provide a
history of any medication the patient is on and to generate the patient's
medication list for any arbitrary point in time. Medication lists that
distinguish between description and prescription and that are exportable in a
standard format can play an essential role in medication reconciliation and
contribute to the reduction of medication errors.
At present, there is no general agreement on how to best implement
medication concepts, records, and lists. The underlying implementation in an
EMR often reflects the needs, culture, and history of both the developers and
the local users. A survey of a sample of medication terminologies (COSTAR
Directory, the MDD, NDDF Plus, and RxNorm) and EMR implementations of
medication records (OnCall, LMR, and the Benedum EMR) reveals the
advantages and disadvantages of each. There is no medication system that
would fit perfectly in every single context, but some features should strongly
be considered in the development of any new system.
Thesis Supervisor: Henry Chueh
Title: Assistant Professor of Medicine
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MEDICATION CONCEPTS
Medications are an integral part of medical care, and an electronic medical
record (EMR) system should be able to present usable medication choices
and useful decision support for order entry, record and surface medication
lists consistently and accurately, and transfer intelligible medication lists to
and from other repositories of patient information.
The atoms of a medication system in an EMR are medication concepts.
Medication concepts can be represented in EMRs at various levels of
standardization and granularity, with various advantages and disadvantages.
At the very least, medications can be represented as "free-text" (strings of
characters without any constraints). This representation is the most flexible,
but has many disadvantages. Each medication concept could be represented
in multiple ways, so that medication lists cannot be recorded in a consistent
fashion. Comparing two medication lists or checking a medication against a
list of allergies would not be straightforward if the same concept can be
represented in more than one way.
A better way to represent medication concepts is as part of an encoded
terminology. Each concept is associated with a single code, so that all
references to that concept refer to the same code. Having a controlled
medication terminology allows the recording of medication lists in a more
consistent fashion and facilitates the development of decision support
services, such as the comparison of medication lists and the checking of
allergies.
Controlled Medication Terminologies
In a controlled medication terminology, the codes associated with medication
concepts could either have intrinsic meaning (also called "smart codes") or
no meaning at all (also called "dumb codes"). While there are some
advantages to using codes that have intrinsic meaning, there are also major
disadvantages, as will become apparent in the discussion of a few controlled
medication terminologies below.
A second choice that has to be made in creating a controlled medication
terminology is what exactly constitutes a medication concept. Is it an active
ingredient? Is it a combination of an active ingredient and a route of
administration? Is it a particular form that an active ingredient takes?
Different controlled terminologies define medication concepts differently.
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COSTAR Directory
The COmputer STored Ambulatory Record (COSTAR) is an EMR initially
developed as a collaborative effort between the Massachusetts General
Hospital (MGH) Laboratory of Computer Science and the Harvard Community
Health Plan (HCHP). As early as 1969, it provided full operational support for
HCHP administrative and medical information processing. COSTAR's
controlled medication terminology is a subset of its overall controlled
terminology, called COSTAR Directory.'
In information science, ontology is the hierarchical structuring of knowledge
about things by subcategorizing them according to their essential (or at least
relevant and/or cognitive) qualities.2 The COSTAR Directory is ontological in
this sense. The COSTAR medication terminology belongs to the "Medical"
branch of the full COSTAR Directory hierarchy.
When COSTAR was designed in the 1960s, computer memory was relatively
limited, and it made good sense to be as efficient as possible in the encoding
of medication concepts. All COSTAR codes consist of a five-character base
code (4 alphabetical characters and 1 check digit) and one or two optional
single-characters modifiers. The first letter indicates the body system (Table
1).
Medications are first organized by body system, and then categorized in
accordance with the hospital formulary. Antibiotics, for instance, all have
codes that begin with the letter D (body system = "Systemic Infections") and
are grouped according to the hospital formulary at the time the terminology
was developed (Table 2).
1 COmputer STored Ambulatory Record User's Manual, p. 1.5 - 1. Massachusetts
General Hospital, 1978.
2 http://dictionary.reference.com/search?q=ontology. Accessed April 24, 2006.
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Table 1. COSTAR Body Systems3
First Letter
B
C
D
E
F
G
H
J
K
L
M
N
p
Q
R
S
T
V
W
Y
Body System
LISTCODES (arrays of other codes)
Systemic
Systemic Infections
Endocrine
Hematologic
Skin
Eye
Ear, Nose, and Throat
Mouth and Teeth
Respiratory
Cardiac
Vascular
Breast
Gastrointestinal
Female Reproductive
Male Reproductive
Renal
Musculo-skeletal
Nervous
Psychiatric
Table 2. COSTAR Antibiotics4
Code Prefix
DS
DSB
DSC-DSD
DSE-DSF
DSG-DSJ
DSN-DSP
DST-DSZ
DTA- DTE
DTF-DTG
DTJ-DTM
DVA-DVE
DVH
DVN-DVW
GTA-GTG
Hospital Formulary #
8:12
8:12.12
8:12.28
8:12.24
8:12.16
8:24
8:12.28
8:16
8:36
8:40
8:20
84:04.12
8:12:04
84:04:08
84:04:16
Class
antibiotics
erythromycins
aminoglycosides (other)
tetracyclines
penicillins
sulfonamides
other antimicrobials
antituberculars
urinary germicides
other antibiotics
antimalarials
scabicides and pediculocides
antifungals
local anti-infectives
The guidelines are
generally assigned
not strict, but trade names and other synonyms are
a single-digit numeric modifier, and forms are generally
3COmputer STored Ambulatory Record User's Manual, p. 3.3 - 3. Massachusetts
General Hospital, 1978.
4 COmputer STored Ambulatory Record User's Manual, p. 3.3 - 6. Massachusetts
General Hospital, 1978.
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assigned a single-letter modifier (Table 3). Modifiers may also be combined
pair-wise, to indicate a form of a trade name, for example.
Table 3. Examples of COSTAR Base Codes and Modifiers
COSTAR Code Medication Concept
DSTW3 ciprofloxacin
DSTW3-1 Ciprox
DSTW3-2 Cipro
DSTW3-3 Cipro XR
DSYS3 ciprofloxacin ophthalmic
DSYS3-O ciprofloxacin ophthalmic ointment
DSYS3-W ciprofloxacin ophthalmic drops
DSYS3-1 Ciloxan
DSYS3-1O Ciloxan ointment
DSYS3-1W Ciloxan drops
COSTAR does not allow more than one concept from the same base code
cluster from being active in the same patient record. This feature prevents
duplication of medications. This restriction also informs the decision of when
new base codes need to be created.
In general, every active ingredient and route combination should have its
own base code. A patient should not be on two oral or two ophthalmic forms
of ciprofloxacin, but could theoretically be on one oral and one ophthalmic
form. Having one base code cluster for oral ciprofloxacin and one base code
cluster for ophthalmic ciprofloxacin has the desired effect.
Certain types of problems occur commonly in ontological classification
schemes,5 and some of these are apparent in this view into COSTAR's
classification of antibiotics.
First, parts of the classification scheme have become less than ideal over
time. For example, new types of antibiotics now in common use, such as
fluoroquinolones and antiretrovirals, do not have categories of their own.
Second, the categorization is optimized for the efficient usage of valid
COSTAR base codes rather than for the most rational classification. The
number of COSTAR base codes is limited because each code must consist of
4 letters and 1 check digit. The initial assignment circa 1969 of COSTAR
code prefixes for the classification of antibiotics optimized the distribution of
codes for the antibiotics known at the time, and did not try to predict how
the formulary of antibiotics would expand over time.
5 Clay Shirky. "Ontology is Overrated."
http://www.shirky.com/writings/ontology overrated.html. Accessed April 24, 2006.
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Since then, the number of new antibiotics has overwhelmed the available
codes under the "other antimicrobials" category, and they had to be
redirected to the previously unused prefix "X." For example, there are
currently 14 antiretrovirals that have base codes that begin with "X," and
they share that prefix with other overflow concepts that may not even be
antibiotics.
Third, an ontological classification system presumes a single correct place to
place an entity. However, this is not the case when an entity can belong to
more than one category. A combination medication such as
enalapril/hydrochlorothiazide is both an antihypertensive agent (prefix "MT")
and a diuretic (prefix "TT"), but it can only be placed in a single category, as
each medication can have only a single code.
Besides the problems inherent in ontological classification schemes in general,
COSTAR's coding system has a few other problems. Because of the
ontological nature of COSTAR Directory, much information about the encoded
concept should be readily apparent from the code itself. The prefix should
indicate the drug class, and the modifier(s) should indicate whether the
medication concept is a trade name and what particular form the medication
concept takes. However, this does not always work as designed.
As already mentioned, the prefix is not always reliable because different
overpopulated drug classes can overflow into the same previously unused
prefixes. Similarly, when an active ingredient, such as guaifenesin, has more
than 9 trade names, the convention of using only single digits as modifiers
for trade names has to be broken.
However, despite these flaws, COSTAR Directory is completely serviceable in
real clinical systems and has survived and thrived over the decades. The
COSTAR controlled terminology has had an uninterrupted existence at
Massachusetts General Hospital (MGH) and continues to serve the EMRs used
by several outpatient care groups at MGH. Medication decision support, such
as links to drug references, suggested dosages, insurance formularies, and
Drug Enforcement Agency (DEA) schedules, are all linked to COSTAR codes.
The COSTAR medication terminology consists of approximately 1958 base
code clusters and 6,898 medication concepts.6
It is worth mentioning that COSTAR is a customizable EMR that has been
widely distributed since its inception. The COSTAR terminology discussed
above is the state of the terminology in the MGH implementation of COSTAR.
Over time, the terminologies in distinct implementations of COSTAR have
diverged, and the same COSTAR code in different COSTAR implementations
cannot be expected to (and most likely will not) refer to the same concept.
-8-
6 As of May 9, 2006.
Partners Master Drug Dictionary
Partners HealthCare was founded in 1994 by Brigham and Women's Hospital
(BWH) and the MGH. It is an integrated healthcare system that includes
primary care and specialty physicians, community hospitals, the two founding
academic medical centers, specialty facilities, community health centers, and
other health-related entities. Partners Information Systems (IS) develops
and maintains clinical applications such as Provider Order Entry (POE) and
the Longitudinal Medical Record (LMR), and these applications rely on a
locally developed medication terminology called the Master Drug Dictionary
(MDD).
In the MDD, there are three types of numeric codes associated with
medication concepts (Table 4). The Rollup-ID represents a routed active
ingredient. It is called a Rollup-ID because it is the active ingredient and a
route "rolled up" into one concept. The Med-ID represents a medication
name and ignores route. The Generic-ID is 0 for a concept that is a generic,
and the Med-ID of the corresponding generic for a concept that is a synonym
or trade name of a generic.
Table 4. Examples of MDD Codes
Rollup-ID Med-ID Generic-ID Medication Concept Route Group
4 4 0 ACETAMINOPHEN oral
4 1497 4 TYLENOL oral
5 11673 0 ACETAMINOPHEN SUPP rectal
5 11820 11673 TYLENOL SUPP rectal
159 137 0 CIPROFLOXACIN injection
160 137 0 CIPROFLOXACIN oral
1263 137 0 CIPROFLOXACIN ophthalmic
Technically, the Rollup-ID is a combination of an active ingredient and a
route group. The "oral" route group, for example includes all of the following
routes: mouth (PO), nasogastric tube (NGT), gastric tube (GT), and
jejunostomy tube (T). However, for simplicity, we will speak of Rollup-ID as
a routed active ingredient.
In the MDD, the basic medication concept is the routed medication. The
Rollup-ID/Med-ID pair uniquely determines the routed medication, and the
Generic-ID can be looked up once the Rollup-ID and Med-ID are known.
In Partners applications, most decision support is based on the Rollup-ID,
because it was decided that the routed active ingredient is the most useful
level at which to consider medications. Even available dosages, which may
differ for different trade names of the same routed active ingredient, is
9
presented to the user based on the Rollup-ID (and therefore are sometimes
inaccurate for particular trade names).
Rollup-ID/Med-ID pairs differ markedly from COSTAR codes in that these
pairs contain no intrinsic information. Whereas drug class, generic status,
and form can sometimes be inferred from a COSTAR code, nothing can be
inferred from a Rollup-ID/Med-ID pair. This is actually an advantage for the
MDD. Information can be attached or detached from a Rollup-ID/Med-ID
pair in separate database tables without affecting the pair itself. On the
other hand, once a COSTAR code is created, it is not possible to change its
implied drug class, generic status, or form.
There are approximately 6,089 Rollup-ID/Med-ID pairs.7
Granularity of Medication Concepts
When coded cleanly, COSTAR base codes are routed active ingredients, and
COSTAR modified codes can be routed trade names, forms of routed active
ingredients, or forms of routed trade names. Therefore, even when coded
cleanly, COSTAR codes can exist on two levels - medication/route and
medication/route/form. Further complicating the terminology are codes that
contain strength, resulting in some COSTAR codes that represent concepts
consisting of medication/route/strength and medication/route/form/strength.
The MDD also contains concepts that exist on a mixture of levels. The most
basic concepts are a combination of medication and route, but there are also
medication/route/form, medication/route/strength, and
medication/route/form/strength combinations.
It turns out that it is non-trivial to define what a medication concept is.
Different purposes require different granularities of medication concepts
(Table 5).
Because COSTAR Directory and the MDD serve multiple purposes, they
encode medication concepts at several levels, rather than a single one. In
the case of describing therapy, sometimes one would actually prefer
recording the drug class rather than the medication itself. For example,
COSTAR Directory has a code for "birth control pills," so that a provider can
record that the patient is on them without needing to specify which particular
ones the patient is taking. If the pills were prescribed by a different provider,
and the patient herself does not know which ones she is taking, recording the
7 As surfaced in the Partners IS Medication Mapping Interchange Data Layer (MMIDL)
Toolkit, alpha release, circa March 2006. MMIDL alpha actually access the quality
assurance (QA) copy of the MDD, which can be up to a few months out-of-date when
compared with the copy in production.
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medication as "birth control pills" would be preferable to guessing the
identity of the medication or not recording anything at all.
Table 5. Pertinent Levels of Medication Granularity for Various Purposes
Clinical Purpose
description of therapy
allergy checking
DEA schedule
drug classification
duplication checking
formulation suggestion
hospital formulary
insurance formulary
dosage suggestion
inpatient order entry
pediatric medications
prescriptions
pharmacy inventory
Most Pertinent Level of Granularity
drug class
ingredient (and drug class to a lesser extent)
active ingredient
active ingredient
active ingredient and route
medication
medication
medication
medication
medication
medication
medication
medication
name and route
name and route
name and route
name, route, and form
name, route, and strength
name, route, form, and strength
name, route, form, and strength
name, form, strength, and packaging
First DataBank National Drug Data File Plus
First DataBank (FDB) is a commercial provider of electronic drug information
to the healthcare industry. FDB's drug knowledge base is called the National
Drug Data File (NDDF) Plus, and medication concepts are encoded as Multiple
Access Points (MAPs).
Because different purposes require medication concepts on different levels,
NDDF Plus comprehensively encodes concepts on four levels: medication
name, medication name/route, medication name/route/form, and medication
name/route/form/strength. Whereas COSTAR Directory and the MDD contain
concepts at different levels in a haphazard fashion, each level in NDDF Plus
contains every possible concept belonging to that level.
These four levels form a strict hierarchy, with the name at the root and the
name/route/form/strength combinations at the leaves. A medication concept
is specified uniquely by a MAP-Level and a MAP-ID (Table 6). Like numeric
codes in the MDD, the MAP-ID is a number that has no intrinsic meaning.
Table 6. Examples of Medication Concepts in NDDF Plus
MAP-Level
Name
Name/Route
Name/Route/Form
Name/Route/Form/Strength
MAP-ID
361
362
5774
160401
Medication Concept
Acetaminophen
Acetaminophen Oral
Acetaminophen Tab [oral implied]
Acetaminophen 325mg Tab
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NDDF Plus contains on the order of 104,476 active concepts, divided among
the four levels (Table 7). Even considering only the name/route level, where
COSTAR and MDD concepts mostly reside, NDDF Plus is significantly larger,
with a total of 22,379 concepts at that level, compared with the 6,847
medication concepts of COSTAR Directory and 6,089 of the MDD.
Table 7. Number of Active NDDF Plus Concepts at Each Levels
Map-Level Number of Concepts
Name 21,391
Name/Route 22,379
Name/Route/Form 25,989
Name/Route/Form/Strength 34,717
The NDDF Plus system has separate database tables that link related
concepts on different levels to each other, trade names to generics,
medication concepts to packaging information, and medication concepts to
drug classes. NDDF Plus also has a controlled terminology for routes, forms,
and strengths.
Having made the massive investment of effort to systematically encode
medication concepts comprehensively at four different levels of granularity
and relating them to each other, NDDF Plus can provide medication concepts
at the appropriate level for many different kinds of decision support.
It is not completely clear that NDDF Plus created the right ontology. Having
a strict hierarchy that branches from name to name/route to
name/route/form to name/route/form/strength help limit that number of
concepts that have to be encoded, but there may be times when concepts
may be needed that do not fit cleanly into this hierarchy. One could argue
that form and strength are more a part of a medication's essence than route.
Take the example of a 325mg tablet of acetaminophen that is intended to be
administered orally. It would be easier to imagine it being administered by a
different route than to imagine it as something other than a 325mg tablet.
Therefore, from this perspective, acetaminophen 325mg tablet is more
correct a concept than oral acetaminophen. Acetaminophen 325mg tablet is
what the thing is. Oral administration is what is done with it.
8 Personal communication from Jaime Medina, Partners IS developer working with
NDDF Plus, circa March 2006. These counts may include non-medication concepts in
NDDF Plus, so they may be an overestimate of the number of medication concepts.
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RxNorm
RxNorm is a controlled terminology of clinical drugs developed by the
National Library of Medicine, with a clinical drug defined as "a pharmaceutical
product given to (or taken by) a patient with a therapeutic or diagnostic
intent." 9 RxNorm is both a source and subset of the Unified Medical
Language System (UMLS) Metathesaurus.
RxNorm medication concepts are also UMLS concepts, and they exist on four
overlapping levels:
1. Ingredient
2. Clinical Drug Component
3. Clinical Drug
4. Clinical Drug Form
(ingredient)
(ingredient + strength)
(ingredient + strength + dose form)
(ingredient + dose form)
There are also equivalents for branded drug concepts (Table 8), and all of
these concepts are connected through well-defined relationships (Figure 1).
Each RxNorm Concept is encoded as a numeric RXCUI, with "CUI" being
short for "concept unique identifier."
Table 8. Examples of Related RxNorm Conceptslo
Type
Ingredient
Clinical Drug Component
Clinical Drug
Clinical Drug Form
Dose Form
Brand Name
Branded Drug Component
Branded Drug
Branded Drug Form
Example
Acetaminophen
Acetaminophen
Acetaminophen
Acetaminophen
Oral Tablet
Tylenol
Acetaminophen
Acetaminophen
Acetaminophen
325 MG
325 MG Oral Tablet
Oral Tablet
325 MG [Tylenol]
325 MG Oral Tablet [Tylenol]
Oral Tablet [Tylenol]
RxNorm links related concepts on different levels to each other, trade names
with generics, and concepts to National Drug Codes (NDCs) for specific drug
products.
9 RxNorm Overview. http://www.nlm.nih.gov/research/umls/rxnorm/overview.html.
Last accessed April 26, 2006.
10 RxNorm Navigator from RxNorm Full Release: 03/14/2006. Searched for
"Acetaminophen 325 MG" on April 26, 2006.
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RXCUI
161
315263
313782
369097
317541
202433
569998
209387
369070
Figure 1. Screenshot of RxNav
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RxNorm also links its names to many other drug terminologies, such as those
of FDB, Micromedex, MediSpan, and Multum. By providing links between
these terminologies, RxNorm can mediate messages between systems not
using the same software and terminology. However, since RxNorm concepts
do not necessarily exist on the same levels of granularity as concepts in
other terminologies, there may not be exact RxNorm equivalents for some
concepts in other terminologies, and the translation cannot be expected to be
perfect.
Dose form consists of route and form, and route and form do not exist
independently in RxNorm. For example, "Acetaminophen Oral Tablet" is a
concept in RxNorm, but "Acetaminophen Oral" and "Acetaminophen Tablet"
are not. Therefore, the concept of"Acetaminophen Oral" in NDDF Plus does
not have an exact equivalent in RxNorm.
Selecting or Creating a Controlled Medication Terminology
There are many commercial controlled medication terminologies on the
market, some with extensive associated knowledge bases. Choosing to use
NDDF Plus, for example, would allow access to FDB's clinical decision support
modules, designed to prevent adverse drug reactions, reduce drug-related
expenses, and otherwise improve the quality of patient care. However,
NDDF Plus's ontology is incongruous to that of RxNorm, which may become
the national standard.
RxNorm has the advantage of being free and having links to many other
medication terminologies. However, it is currently incomplete. The stated
scope of RxNorm is as follows:
RxNorm is intended to cover all prescription medications approved for use in
the United States. Prescription medications from other countries may be
included as opportunities allow, a principal consideration being that there be
an authoritative source of information about these drugs. OTC [over-the-
counter] medications will be added and covered, as well, when reliable
information about the medications can be found and when they appear to be
represented in other UMLS source terminologies. Medications, whether
prescription or OTC, with more than three ingredients are not fully
represented at the present time. In some cases (e.g., multivitamins) it may
not be possible to include all of them in a reasonable time frame. 12
Creating a local controlled medication terminology is possible, as evidenced
by the existence of COSTAR Directory and the MDD. When creating a new
terminology, one has the opportunity of designing the underlying ontology to
fit the needs of the EMR that uses the terminology.
12 RxNorm Overview. http://www.nlm.nih.gov/research/umls/rxnorm/overview.html.
Accessed April 26, 2006.
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In some hospitals, one can order "Magic mouthwash" or "Miracle mouthwash"
for painful oral mucositis. However, these are not manufactured medications,
but are compounded locally, and not necessarily using the same compounds
in different places. In COSTAR Directory and the MDD, Miracle mouthwash
consists of diphenhydramine, lidocaine, and Kaopectate (bismuth). Miracle
mouthwash used in other places may use Maalox (aluminum hydroxide,
magnesium hydroxide, and simethicone) instead of Kaopectate. Using a
customized local terminology gives the flexibility to define medication
concepts in a way that corresponds with local practice.
It is also possible to include substances that are not technically medications,
but for many purposes act as medications. COSTAR Directory and the MDD,
for example, both include "beer" as a medication concept (COSTAR code
QSTA7; Rollup-ID 72, Med-ID 61). While this may appear strange, there are
advantages to being able to manipulate "beer" as a medication concept, such
as checking for interactions with other substances.
COSTAR Directory also includes international medications as medication
concepts. For a number of reasons, patients at MGH are sometimes on
medications purchased in foreign countries (including Canada), and there
may not always be an equivalent medication available in the United States.
It therefore is useful to be able to record these medications and link
appropriate decision support to these international medications.
The main problems with creating a local terminology is that it takes a lot of
resources to maintain and one needs to map it to a recognized standard
terminology for the sake of interoperability with other systems.
Ideally, one would like to have the simple, rational ontology and widespread
acceptance of RxNorm, the comprehensiveness and extensive knowledge
base of NDDF Plus, and the flexibility of COSTAR and MDD.
In any case, it is important to keep in mind the following points about
medication terminologies:
1. A controlled terminology is essential for implementing medication
decision support.
2. Medication concepts can exist at many different and possibly
overlapping levels of granularity (specification).
3. Different levels of granularity are appropriate for different decision
support services.
4. Ontology can limit the types of levels allowed, but care should be
taken to choose levels that reflect reality or are otherwise useful in
decision support.
5. The more levels that are encoded, the more resources it will take to
cover all medications comprehensively at each level.
6. While standardization is important for interoperability between
systems, there are still situations in which local customization is useful.
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MEDICATION RECORDS
Having a controlled medication terminology is not enough. Medications must
be recorded in context, which includes all the usual information that is
collected on a prescription or inpatient order and any other information that
is relevant from the perspective of the EMR.
Examples of Medication Records
OnCall Clinical Web Portals
With the emergence of the Web, the MGH Laboratory of Computer Science
developed OnCall, a Web-based front-end to COSTAR. The OnCall
application architecture is based on Web services and Extensible Markup
Language (XML). In OnCall, medication records were originally stored in the
form of XML patient notes (a strict hierarchical format). Recently, however,
data from OnCall notes were transferred to relational databases (Figure 2).
In OnCall, medication records are saved as "events." Events are uniquely
defined by the patient (Patient_Person_ID), the medication concept's code
(ConceptId and ConceptIdScheme), the patient note that includes this record
(DocumentIndexGUID), and the type of event ([action]). For now, the
ConceptIdScheme is COSTAR and the ConceptID is the medication concept's
COSTAR code, but this database leaves open the opportunity to include or
migrate to a medication terminology other than COSTAR Directory. Start and
stop times are associated with events.
Dosage forms are one level removed, and consist of strength and form. Each
event, and thus each medication concept, may be associated with one or
more dosage forms. Each dosage form, in turn, may be associated with one
or more dosing regimens, which may consist of dose (the actual quantity of
the dosage form), route, frequency, PRN (for use as needed) duration, and
directions. Among other things, this means that a dosage form may have
more than one associated route.
Finally, each dosage form may be associated with one or more prescriptions,
which may consist of the quantity of the dosage form, the number of refills
for the prescription, the option to substitute the generic for the trade name,
and the prescribing healthcare provider. These prescriptions are independent
of the dosing regimens.
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Figure 2. OnCall Medication Database Diagraml3
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It is interesting to note that this database structure describes ontology
different from that of the underlying COSTAR terminology. In COSTAR, the
MDD, and NDDF Plus, route is more essential to a medication concept than
form. The OnCall database, on the other hand, considers form more
essential than route.
The OnCall medication database structure is clearly not bound to using
COSTAR, leaving open the option of eventually including or migrating to
another terminology. However, neither the MDD nor NDDF Plus is a natural
fit for this structure either. RxNorm is a better fit, but in RxNorm, "dose
form" is defined as route and form, whereas in OnCall, "dosage form" is
defined as strength and form.
Unfortunately, as the example of dose form/dosage form illustrates, similar
terms can mean different things in different terminologies.
13 Personal communication from Wayne Raila, OnCall developer. The diagram was
last updated January 24, 2005.
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Longitudinal Medical Record
LMR is the outpatient medical record designed and maintained by Partners IS.
The medication terminology it uses is the MDD. The LMR provides a XML
data service that surfaces medication records as follows:
<Medication-List>
<Medication>
<Rec-ID />
<MPI-ID />
<Service-Date />
<Med-Name />
<Generic-ID />
<Rollup-ID />
<Med-ID />
<Med-Freq/>
<Med-Route />
<Dose />
<Units />
<Take-dose />
<Take-units />
<Dispense />
<Dispense-units />
<Duration />
<Duration-units />
<Refills />
<PRN />
<Rx />
<No-substitutions />
<Directions />
<Comments>
<Start-date />
<End-date />
</Medication>
</Medication-List>
The LMR medication record XML is fairly straightforward. The structure is flat,
and all the basic pieces information, such as route, dose, frequency, duration,
PRN, quantity, and refills, are included in one place. Note that the underlying
medication terminology (using Rollup-ID and Med-ID) is built into the
structure of the medication record, so that it would have to be adjusted to
accommodate other medication terminologies.
Benedum Geriatric Center EMR
The Benedum Geriatric Center (BGC) is a multidisciplinary geriatrics clinic at
a university medical center serving a patient population of approximately
2,000, and the EMR was developed specifically to address the problem of
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medication data error. 14 Medication concepts are identified as a numeric
formulary.id, and can a combination of name, strength, and form, e.g.,
"ampicillin, 250-mg tablet." This EMR thus appears to depend on the
formulary for its medication terminology.
Table 9. The Benedum Geriatric Center EMR Medication-Record Schema15
Medication-record Schema in the Benedum Geriatric Center Electronic Medical Record
Field Name Type Description
I m1ealcatiuil.id Nuimber (Loxig) Prnimary Key
2 pid Number (Long) Foreign key for the patient record
3 med.ancestor Number (Long) Medication-id of the record from which this record was created due to
a dose change or correction
4 created.date Date/Time Date record was created
5 created-who Text Name of provider who created this record
6 creator-id Number (Long) Foreign key to provider table
7 created reason Text Whether the event was a dose change or correction
8 created-encounterlD Number (Long) Foreign key to the encounter table
9 archived-date Date/ime Date record became inactive
10 archived-reason Text Reason why record made inactive
11 archived-who Text Name of provider who made record inactive
12 archived-encounterlD Number (Long) Foreign key to encounter table
13 archiver-id Number (Long) Foreign key to provider table
14 formulary id Number (Long) Foreign key to formulary
15 sig-value Text Number of units of medication
16 sig units 'text Units (e.g., tablet)
17 sig ..route Text Route of administration
18 sig.interval Text Interval of administration
19 sigprn Text Whether medication is prn
20 sig-comnments Text Free-text comments
21 who Text Name of provider
22 provider-id Number (Long) Foreign key to provider table
23 disp.number Number ([nt) Quantity dispensed
24 disp. units Text Units dispensed (e.g., tablets)
25 disp..refills Number (Int) Number of refills
26 disp.date Date/Time Date of last dispensing
27 disp.encounterlD Number (Long) Foreign key to encounter table
28 disp..who Text Name of provider who last dispensed
29 dispenser. id Number (Long) Foreign key to provider table
30 disphp Yes/No Whether the medication requires a prescription
31 verified date Date/Time Date the medication was last checked with the patient
32 verified. who Text Name of provider who checked medication
33 verified-encounterlD Number (Long) Foreign key to encounter table
34 verifier. id Ntumber (I iong) Foreign key to provider table
The BGC EMR's medication record
noteworthy for linking a record to
is similar to the LMR's. However, it is
its predecessor record (ancestor.id) and for
recording the name and numeric ID of the provider making changes to the
medication under consideration. This provides an easy way to track the
history of the patient's use of the medication. The record also explicitly
records when the medication was last verified with the patient and the
provider who performed the verification. We will discuss the meaning and
importance of confirming medications later.
14 Wagner WM, Hogan WR. The accuracy of medication data in an outpatient
electronic medical record. JAMIA. 1996; 3(3): 234-244.
15 As published in Wagner et al.
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Recommendations for Implementing Medication Records
Just as there is no agreement on what medication concepts should be, there
is no agreement on what medication records should be. However, some
common elements are included in all three implementations described above
(Table 10).
Table lo. Common Elements in Medication Records
Field Comment
medication record ID primary key
medication concept preferably able to accommodate multiple medication
terminologies
patient ID foreign key for the patient
strength strength of discrete unit or concentration of substance
dose number or fraction of discrete units or quantity of
substance per dose
route
frequency
PRN indicator for whether the medication is only to be used as
needed (PRN)
directions
quantity
refills
prescription start time
prescription stop time not always mathematically related to quantity and refills
However, many other pieces of information are worth recording (Table 11).
If implemented with all the recommended pieces of information, medication
records will exist as bidirectional chains. A new medication will start a new
chain. Any change to an existing medication would be a link added to an
existing chain. From any record, one could go up or down the chain to the
previous or next record of this medication, respectively.
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Table 11. Other Desirable Elements in Medication Records
To construct a list of a patient's medications (active and inactive) as it was
on any particular time of interest, the EMR could use the following logic:
1. Query the database for all medication records associated with the
patient ID.
2. Filter out all records that have a non-NULL"replaced by" field. This
leaves only the most recent record for each medication record chain.
3. For each chain, do the following to find the relevant record in the chain.
a. If the documentation time of the record at the end of the chain
is the same as or earlier than the time of interest, this is the
relevant record in this chain.
b. If the documentation time of the record at the end of the chain
is later than the time of interest, move up the chain to the first
record with a documentation time that is the same as or earlier
than the time of interest. If no earlier record fits these
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Field Comment
regimen large free-text field for complicated regimens, such as
variable strength or dose, cyclic frequency, or taper
PRN condition condition under which a PRN medication should be used
substitution flag indicator for whether a substitution is allowed
encounter ID foreign key for the related office visit, telephone call, email,
or other patient communication
record type one of the following:
* addition
* change
. renewal
* completion
* discontinuation
* reactivation
* verification
reason/indication
action/documentation distinction for indicating whether the record is an action
being taken or a documentation of an action taken by
someone else
actor ID person who performed the action
actor name ID may be unavailable, such as for a provider outside the
EMR system or the patient himself
documenter ID the person who documented the action
documentation time also known as "service date"
actual start time
actual end time
comments
replaced by link to medication record of that replaced this record; is
NULL if this is the most recent record for this medication
history link to medication record replaced by this record; is NULL if
this is the first record for this medication
requirements, drop this chain. (The medication was first
documented at a time later than the time of interest.)
4. Separate out records that have record type of "completion" or
"discontinuation." List these as "inactive medications."
5. Separate out remaining records that have "prescription end time"
earlier than the time of interest. List these as "potentially inactive
medications."
6. Separate out remaining records that have "prescription start time"
later than the current time (and a NULL "actual start time"). List these
as "medications to be started."
7. List the remaining medications as "active medications."
To get the current list, set the time of interest to the current time.
For both patient care and legal purposes, it is important to make a distinction
between someone who is actually changing the status of a medication and
someone who is merely documenting a change made by someone else. It is
also important to document when medications were last verified with the
patient, even when no changes are made.
Finally, the entire history of a patient's use of a particular medication can
easily be discovered by successively following the links in the history field of
the associated medication records.
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MEDICATION LISTS
It is vitally important for patient care to have an accurate list of the patient's
medications. As we already described, if the medication records are up to
date, it is straightforward to generate a list of the patient's current
medications. However, there are still subtleties to medication lists that need
to be considered.
As described in the above section, it is possible to construct a medication list
for any arbitrary point in time in the past or present. Because we do not use
any records with documentation times later than the time of interest, the list
we construct is always the same, regardless of when we construct it.
To avoid redundancy, a medication list can be constructed and stored as a
list of links to medication records rather than with the actual medication data.
The list should be linked to the patient and the specific encounter with the
patient and indicate the type of list (Table 12).
Table 12. Proposed Database Fields for Medication Lists
Field Comment
medication list ID primary key
patient ID foreign key for the patient
encounter ID foreign key for the related office visit, telephone call, email, or
other patient communication
list type descriptive or prescriptive
documentation date
documenter ID the person who documented the list
records foreign keys for the associated medication records
Descriptive versus Prescriptive Medication Lists
A medication list can be descriptive, prescriptive, or a combination of both. A
descriptive medication list describes what the patient is taking. A
prescriptive medication list describes what the patient should be taking,
especially from the point in time at which the list is constructed. Sometimes
a list contains some records that are descriptive and some records that are
prescriptive.
It is best to separate descriptive lists from prescriptive lists. The two types
of lists serve useful, but different, purposes. Discrepancies between a
descriptive list and the immediately preceding prescriptive list show changes
in medication usage since the prescriptive list was constructed. Such
changes could include both provider-initiated changes and patient-initiated
changes, including problems with compliance.
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Symptoms and disease progression should be interpreted in light of the
descriptive medication list to see how well the medications are working,
whether they are causing any side effects, and whether there are any
interactions among them. For these purposes, it is more important to know
what the patient is actually taking than what he is supposed to be taking.
Prescriptive lists can be checked for potential drug-drug interactions and
allergic reactions. They can also be given to the patient so that a patient has
a current list of all the medications that he should be taking and how he
should be taking them.
Lists that are a mixture of descriptive and prescriptive elements are
confusing and should not be used unless each element is clearly designated
as one or the other.
Reviewing versus Verifying Medications
There are times when a healthcare provider will review a patient's medication
list without actually verifying each medication with the patient. The provider
may do this when complete accuracy is not crucial to the task at hand, or
when it is simply impossible to verify the medications with the patient at that
point in time. For example, a provider may review the patient's medication
list to get a general idea of the patient's medical problems before providing
some minor treatment. If an unconscious patient presents to an emergency
ward, a physician may review the patient's medication list in the EMR, but be
unable to verify it until the patient regains consciousness.
There is value to reviewing medication lists, and there is value to
documenting that a medication list has been reviewed, but review should be
differentiated from verification. There is no need to update a medication
record when the medication is only reviewed, as there is no basis to make a
change to the record.
On the other hand, verification should be documented as a medication record
with the verification time as the documentation time. Verification serves the
important function of confirming that the medication record is still accurate
at a time more recent than previously recorded.
Recommendations for Implementing Medication Lists
Because medication lists can be constructed from the underlying medication
records, accurate medication lists can be maintained by maintaining accurate
medication records.
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When there is sufficient time, it would be good practice to create a
descriptive medication list at the beginning of the provider-patient interaction
and a prescriptive medication list at the end of the interaction. The provider
should begin by asking the EMR for a current medication list. The EMR would
construct one from the medication records in the manner already described.
When there is sufficient time in a patient encounter, the provider should
verify each medication on the medication list. If any medication is not being
taken the way it was prescribed, the provider should document who made
the change (such as another provider or the patient himself) and how it is
actually being taken. If the patient is taking new medications, the provider
should document who is responsible for the new medication, when the
medication was started, and how the patient is taking it. At the end of this
process, the medication list becomes a descriptive list of what the patient is
taking. This list should be saved in the medication list database as a
descriptive list associated with this patient and this encounter.
By the end of the provider-patient interaction, the provider will have made
any necessary changes to the patient's medications. Perhaps the provider
prescribed new medications, changed the dose or schedule of existing
medications, and even discontinued a few. At the end of the interaction, the
provider should ask the EMR for a current medication list, which would
incorporate all the changes the provider made throughout the course of this
interaction. This list should then be saved in the medication list database as
a prescriptive list associated with this patient and this encounter. This list
could also be printed and given to the patient as an up-to-date list of what he
should be taking.
Implementing medication records and medication lists as described above
makes it easy to retrieve relevant medication lists. When pulling up the note
for a particular patient encounter, the EMR can load and display any
descriptive and prescriptive medication lists associated with that encounter.
If no lists were specifically saved in association with that encounter, the EMR
can construct and display, in real time, a medication list for the time of the
encounter. This list, however, may be partly descriptive and partly
prescriptive.)
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EXCHANGING MEDICATION DATA
Accurate medication data is vital to providing good healthcare, but data is
often scattered among the EMRs used at the various locations where a
patient receives care. During each patient encounter, the provider often
needs to expend time and effort on resolving discrepancies between what the
patient is actually taking and what is recorded in the local EMR.
It would be ideal if the local EMR could gather medication data directly from
other EMRs. While this would not help in the case of patient-initiated
medication changes, it would help in the case of changes initiated by other
providers. The local EMR would gather the most up-to-date medication lists
from the other EMRs and allow the provider to modify the local medication
list as needed.
The main problem in sharing medication data is that different EMRs use
different medication terminologies and different implementations of
medication records and medication lists.
Standards for Exchanging Medication Data
Developing medication standards for the purposes of exchanging medication
data is not a trivial task. Health Level Seven (HL7) is a Standards
Developing Organization (SDO) accredited by the American National
Standards Institute (ANSI) to produce standards in the domain of clinical and
administrative data.1 6 Its mission is to create flexible, cost-effective
approaches, standards, guidelines, methodologies, and related services for
interoperability between healthcare information systems.17
It is HL7's position that while data can be exchanged between systems, its
usefulness is compromised unless there is shared, well-defined, and
unambiguous knowledge of the meaning of the data transferred. Medications
that are available are finite, countable, and identifiable, and of all concepts
that require representation in EMRs, medications should be the most
straightforward to implement. However, there are no still no universally
accepted standards for naming them.
The Food and Drug Administration's National Drug Code (NDC) is nationally
recognized, but it is flawed because the codes can be reused, so that the
same code can refer to different medication concepts at different times. NDC
codes are also product-oriented and are assigned by the manufacturers
16 http://www.hl7.org/. Accessed May 8, 2006.
17 Cimino J1, Huff S, Broverman C, McNamara T, Nelson S.. Development of a
Standard Terminology to Support Medication Messages. SCAMC 1998.
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rather than centrally. SNOMED, another available standard, has an opposite
problem. It does not provide codes to the level of the actual products.
The HL7 Terminology Special Interest Group (SIG) consists of drug
knowledge base vendors, users, regulators, and many others. They review
the data models of the various vendors in order to develop a unifying model
for sending and receiving medication messages. Their approach to
terminology development is to collaborate with other SDOs and medication
terminology builders, reference existing terminologies, and add only items
that do not already exist.
The HL7 Terminology SIG recognizes that medication concepts at many
different levels of granularity are useful: clinical drugs, trademark drugs,
composite clinical drugs, composite trademark drugs, manufactured
components, packaged products, and "not fully specified" drugs. "Birth
control pills" for example, would be a not fully specified drug that could still
serve a real and important purpose in documentation.
Mapping between Medication Terminologies
One strategy to achieve interoperability is to map medication terminologies
to each other. However, there are a number of problems with this.
Terminologies may not agree on what medication concepts should be or what
levels of granularity are acceptable. COSTAR Directory and the MDD favor
routed medications, but include some concepts with form and/or strength
information. NDDF Plus can accommodate name, name/route,
name/route/form, and name/route/form/strength combinations. Concepts in
RxNorm are on the levels of name, name/strength, name/route/form, and
name/strength/route/form.
If one intends to map a concept in one terminology to a concept in another
terminology, one may have to cross levels. For example, given the RxNorm
concept of"Acetaminophen 325mg," it is unclear what it should be mapped
to in NDDF Plus. "Acetaminophen" (level = name, MAP-ID = 361) is too
broad, but Acetaminophen 325mg Tab (level = name/route/form/strength,
MAP-ID = 160401) is too narrow.
In the best case scenario, mapping is one-to-one, but sometimes there are
no equivalent concepts and sometimes there are multiple equivalent
concepts. This can occur because of an anomaly in one or both terminologies
or simply because the terminologies do not agree on what are allowed as
medication concepts.
The exactness of mapping that is required depends on the intended purpose.
In checking for allergies and drug-drug interactions, for example, it is
sufficient to map concepts in one terminology to concepts in another that
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have the same ingredients. On the other hand, for formulary purposes, it is
important to map trade names exactly.
The question of what is adequate mapping depends on the context, and the
context can be any of the following:
* description of therapy
* allergy checking
* DEA schedule
* drug classification
· duplication checking
* formulation suggestion
* hospital formulary
* insurance formulary
* dosage suggestion
* inpatient order entry
* pediatric medications
* prescriptions
* pharmacy inventory
One possible solution is to grade mappings so that it is clear what purposes
the mappings can be used for.
One-Way versus Two-Way Mapping
If a concept in one terminology is mapped to a concept in another, the
reverse mapping is not necessarily a good one. For example, "Calcitrate" is a
trade name of"calcium citrate" and is included in COSTAR Directory, but not
in the MDD. One could reasonably map "[COSTAR] Calcitrate" to "[MDD]
CALCIUM CITRATE." However, going in reverse, one would not want to
presume that the best COSTAR equivalent of"[MDD] calcium citrate" is
"[COSTAR] Calcitrate." In fact, the best mapping from MDD to COSTAR in
this case is to "[COSTAR] calcium citrate."
[COSTAR] calcium citrate -> [MDD] CALCIUM CITRATE (oral)
[COSTAR] Calcitrate -> [MDD] CALCIUM CITRATE (oral)
[MDD] CALCIUM CITRATE (oral) -> [COSTAR] calcium citrate
From a graded one-way mapping, it is possible to use some logic to reverse
the mapping. However, this is translating to and back from another
terminology, and the loss of information in the double translation can be
significant.
To get a true two-way mapping between two terminologies, one would have
to construct two one-way mappings.
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Trying to map all terminologies to each other pair-wise would be a
combinatorial nightmare. If each pair of terminologies were to have two
mappings between them (one going each way), then n terminologies would
require a total of n x (n-i) mappings. For example, if we wanted pair-wise
mappings among COSTAR Directory, the MDD, NDDF Plus, and RxNorm, we
would require 12 mappings. In general, the number of mappings required
will be on the order of the square of the number of terminologies.
Mapping COSTAR Directory to the Master Drug Dictionary
A direct one-way mapping was made between COSTAR Directory and the
MDD. The intended purposes of the mapping were the following:
· To export OnCall medication lists (based on COSTAR Directory) with
the equivalent MDD codes, so that the OnCall lists can be used to
update the lists in MDD-based EMRs.
· To leverage the MDD medication knowledge base for use in decision
support in OnCall.
· To open up the option of migrating OnCall from using COSTAR
Directory to using the MDD.
* To investigate how much a one-way mapping may inform a two-way
mapping.
A simple ranking system was used, with a lower-numbered Rank indicating a
better mapping (Table 13).18
Table 13. Quality of the COSTAR-to-MDD Mapping
Rank Description Count Fraction
1 Good map 3,872 56.1%
2 Missing brand or synonym 707 10.2%
3 Probable map 145 2.1%
4 COSTAR concept is broader than MDD concept 205 3.0%
5 Ambiguous 6 0.0%
6 MDD is missing this concept 450 6.5%
7 COSTAR concept is not a valid medication 1,513 21.9%
Total 6,898 100.0%
In general, a lower-numbered rank indicates a better mapping. A Rank of 6
or 7 actually indicates that no reasonable mapping can be made, with the
problem being in the MDD or COSTAR Directory, respectively.
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18 As of May 9, 2006.
The default route in COSTAR is oral if the medication is available orally.
Otherwise, the default route is the most common non-oral route. In general,
generic medications start with a lowercase letter and trade name medications
start with an uppercase letter.
The following are Rank 1 mappings from COSTAR concepts to MDD concepts:
* G CSF-> FILGRASTIM (G-CSF) injection
* leucovorin -> LEUCOVORIN CALCIUM oral
* Citracal -> CITRACAL (CALCIUM CITRATE) oral
There are two types of Rank 2 mappings. The first type is a COSTAR
concept that is a valid' 9 synonym or trade name of a concept in the MDD, but
the concept itself is not in the MDD. The second type is a COSTAR concept
that is not a valid synonym or trade name, but the active ingredient can be
inferred from the base code. Both types of COSTAR concepts are mapped to
the MDD concept for the active ingredient.
* Vi dom "A" -> VITAMIN A oral
* Calcitrate -> CALCIUM CITRATE oral
* Folgard -> FOLIC ACID/PYRIDOXINE HCL/CYANOCOBALAMIN oral
Rank 3 mappings are inexact, but any error is probably insignificant.
* Betalin -> BETALIN COMPLEX (THIAMINE HCL) oral
* multivitamins and minerals -> MULTIVITAMINS oral
* Stuart prenatal with folate -> STUART-NATAL (PRENATAL MULTIVITAMINS)
oral
When a COSTAR concept is broader than any MDD concept, the COSTAR
concept is mapped to multiple MDD concepts, and each mapping is Rank 4.
* acetaminophen and codeine -> ACETAMINOPHEN W/CODEINE 15MG oral
* acetaminophen and codeine -> ACETAMINOPHEN W/CODEINE 30MG oral
· acetaminophen and codeine -> ACETAMINOPHEN W/CODEINE 60MG oral
· acetaminophen and codeine -> ACETAMINOPHEN W/CODEINE ORAL LIQUID
oral
Note that there is no MDD concept for simply "ACETAMINOPHEN
W/CODEINE." Depending on the context, one of the MDD concepts could be
the right mapping, but they cannot all be the right mapping at the same time.
Sometimes, there is reason behind a mapping, but the mapping is much less
than ideal. These mappings are Rank 5.
* perphenazine concentrate -> PERPHENAZINE oral
* phenylephrine solution -> PHENYLEPHRINE HCL nasal
19 A COSTAR concept is "valid" if it can be found in widely accepted drug knowledge
references, such as Lexi-Comp Online (http://www.crlonline.com/crlonline).
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When the COSTAR concept is valid (or is a modifier of a valid base code
concept), and there is nothing reasonable to map to in Partners, the COSTAR
concept are mapped to NULL and the mapping are Rank 6.
* Lenograstim
· niacin injection
* vitamin B2 injection
Finally, there are times when the COSTAR concept is not valid as a
medication concept, possibly because of obsolescence, the use of a rare
synonym, or irresolvable ambiguity. These concepts are mapped to NULL
and the mappings are Rank 7.
* 4 way nasal spray
* Birth control pills
. Perihemin
Ranks 1 to 3 denote good one-way mappings. Of the 6,898 COSTAR
medication concepts, 4,724 (68.4%) have one-to-one mappings of this
quality. Another 3.0% have good one-to-many mappings (Rank 4). This
gives a total coverage of 71.4% in the mapping from the medication subset
of COSTAR Directory to the MDD.
While this may seem low, it turns out that the COSTAR concepts that do not
have good mappings to the MDD are ones that are much less frequently or
no longer used. Between March 1, 2005, and March 20, 2006, OnCall users
documented, added, reactivated, renewed, or changed 221,077 medication
records for their patients. Inactivations (completions or discontinuations)
were not counted. These 221,077 prescriptions referred to 2,479 distinct
COSTAR concepts (Table 14).2°
There is reason for optimism. While only 68.4% (Ranks 1 to 3) of COSTAR
concepts have a good equivalent in the MDD, these COSTAR concepts cover
95.3% of recent active medication records. If we include the one-to-many
Rank 4 mappings, which would require some human user interaction or
sophisticated logic to choose the right mapping depending on the context,
then the COSTAR-to-MDD mappings cover 98.2% of recent active medication
records.
Of the 1.8% not covered by good mappings, 1,761 (68.0%) do not refer to
COSTAR concepts. In these medication records, users did not select an
existing COSTAR concept, but put in free text in the medication concept field.
The majority of the rest consist of nutritional supplements, vague drug
classes (instead of identified medications), or herbal medications.
20 Personal communication from Mary Morgan, OnCall developer.
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Table 14. Active OnCall Medication Records from March 1, 2005, to
March 20, 2006
Map Rank Records % Records Concepts % Concepts
NULL2 ' 4 0.0% 3 0.1%
1 208,252 94.2% 2,012 81.2%
2 983 0.4% 112 4.5%
3 1,595 0.7% 68 2.7%
4 6,394 2.9% 124 5.0%
5 0 0.0% 0 0.0%
6 1,258 0.6% 64 2.6%
7 2,591 1.2% 96 3.9%
Total 221,077 100.0% 2,479 100.0%
Without further testing, one cannot be sure that 98.2% coverage is sufficient
for decision support purposes. However, it is likely that this mapping is
adequate to leverage MDD-based decision support in a COSTAR-based EMR.
Reversing a One-Way Mapping
Creating the one-way mapping from the medication subset of COSTAR
Directory to the MDD was a labor-intensive process. It required access to
the entirety of COSTAR and the ability to search MDD concepts by name.
A one-way mapping allows the exportation of COSTAR-based data to an
MDD-based EMR and the possibility of using MDD-based medication
knowledge in a COSTAR-based EMR. However, to maximize interoperability,
it is necessary to have a two-way mapping between the medication
terminologies.
Reversing the one-way mapping from COSTAR to the MDD would leverage
the work that has already been done. It will not be adequate for a full two-
way mapping, but it would be a start. The quality of a one-way mapping
changes when it is reversed, and this must be taken into account. Let us use
Reverse-Rank to denote the quality of the reversed mapping (Table 15).
Rank 1 mappings are good one-to-one mappings and reverse very well. The
reverse mappings have Reverse-Rank 1.
Rank 4 mappings are one-to-many mappings and reverse well. The reverse
mappings have Reverse-Rank is 2.
21 There are concepts in COSTAR Directory that have been intentionally left out of
the OnCall reflection of COSTAR Directory. A new record referring to one of these
concepts cannot be created in OnCall, but a record already referring to one of these
concepts can be renewed in OnCall. No attempt has been made to map these
deprecated COSTAR concepts to MDD concepts.
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Rank 3 mappings are fairly good one-to-one mappings and can be reversed.
The reverse mappings have Reverse-Rank 3.
Rank 2 mappings are good one-way, but poor when reversed. The reverse
mappings have Reverse-Rank 4.
Mappings of Ranks 5 are already unreliable and reversing it would reduce
reliability even more. Mappings of Ranks 6 and 7 are to NULL and cannot be
reversed.
Table 15. Examples of Reversing COSTAR-to-MDD Mappings
Rank Reverse- COSTAR Concept MDD Concept
Rank
1 1 G CSF CALCIUM CITRATE oral
2 4 Vi dom "A" VITAMIN A oral
3 3 Betalin BETALIN COMPLEX (THIAMINE
HCL) oral
4 2 acetaminophen and ACETAMINOPHEN W/CODEINE
codeine 30MG oral
5 N/A perphenazine concentrate PERPHENAZINE oral
6 N/A Lenograstim N U LL
7 N/A 4 way nasal spray NULL
In the original mapping, distinct COSTAR medication concepts can map to the
same MDD concept. Therefore, reversing the mappings can and does result
in some one-to-many mappings.
What we really want is a one-to-one reverse mapping, so we need a tie-
breaker to choose between the many whenever we have a one-to-many
situation. We can use the following logic:
1. If an MDD concept reverse maps to multiple COSTAR concepts, and
these mappings are not all of the same Reverse-Rank, keep only the
mappings with the best (lowest) Reverse-Rank.
2. If two COSTAR concepts map to the same MDD concept, and one of
these COSTAR concepts is a base code and the other is a modifier of
this base code, then we prefer to reverse map the MDD concept to the
base code. This is because the MDD concept is probably a generic
rather than a trade name (because a COSTAR base code maps to it),
and therefore the reverse mapping should be to the generic (the
COSTAR base code) rather than possibly a trade name (the COSTAR
modified code).
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3. If multiple COSTAR base codes map to the same MDD concept or if
only modified COSTAR codes map to the same MDD concept, then
there is no a priori reason to choose any one over another. Arbitrarily,
choose the one that is first alphabetically.
Let us go through an example to clarify this logic. Many COSTAR codes map
to the MDD concept of"ACETAMINOPHEN oral," and the mappings have
different Ranks. This leads to a one-to-many reverse mapping from
"ACETAMINOPHEN oral" to COSTAR concepts (Table 16).
Table i6. Representative Subset of the Reverse Mapping of the MDD
Concept "ACETAMINOPHEN oral" to COSTAR Concepts
MDD Concept COSTAR Concept Rank Reverse- COSTAR
Rank Code
ACETAMINOPHEN oral acetaminophen 1 1 WSHL1
ACETAMINOPHEN oral acetaminophen liquid 1 1 WSHL1-Q
ACETAMINOPHEN oral Anuphen 2 4 WSHL1-1
ACETAMINOPHEN oral Capital 2 4 WSHL1-2
Note that these are all acceptable mappings from COSTAR to MDD (Ranks 1
and 2). However, the reverse of the Rank 2 mappings are poor. We do not
want "ACETAMINOPHEN oral" to map to any specific trade names, if we can
help it. Since we have a choice between Reverse-Ranks of 1 or 4, we can
eliminate the reverse mappings with Reverse-Ranks of 4.
That leaves us with two possible mappings. Mapping "ACETAMINOPHEN oral"
to "acetaminophen (WSHL1)" is clearly preferable to mapping it to
"acetaminophen liquid (WHSL1-Q)." Fortunately, our second rule tells us to
prefer the base code, WHSL1, to the modified code, WHSL1-Q, when there is
a tie in Reverse-Rank.
We are then left with the single mapping for MDD's "ACETAMINOPHEN oral"
to COSTAR's "acetaminophen" [oral implied], which is the desired result.
Applying the above logic to the reverse mappings results in each distinct
MDD concept having only a single mapping to COSTAR (Table 17). By
reversing the COSTAR-to-MDD mapping, we obtain an MDD-to-COSTAR
mapping for 3,197 of the 6,089 MDD concepts. That is 52.5% coverage of
the MDD. This is most likely insufficient for clinical purposes. However, pre-
mapping 52.5% of the MDD medication terminology saves about half the
work that needs to be done to map the entire MDD to COSTAR Directory.
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Table 17. Quality of the Reverse of the COSTAR-to-MDD Mapping, Before
and After Reducing One-to-Many Mappings to One-to-One Mappings
Reverse-Rank Count (with 1-to-many) Count (only 1-to-1) % Reduction
1 3,892 2,814 27.7%
2 531 326 38.6%
3 144 48 66.7%
4 751 9 98.8%
Total | 5,318 3,197 39.9%
Mapping Terminologies to a Single Common Terminology
The COSTAR Directory and the MDD are constantly being updated to add new
medications that come onto the market, to remove medications that have
been removed from the market, and to correct errors. To maintain a two-
way mapping between the two terminologies would require the mapper to
keep track of changes in either vocabulary and add or adjust the two-way
mapping as needed. The mapper requires knowledge and access to both
terminologies.
We already mentioned the combinatorial nightmare of creating pair-wise two-
way mappings. However, maintaining all these mappings is an even greater
problem. Any change in one terminology can potentially affect mappings
from that terminology to and from every other terminology, and a group of
mappers with a collective knowledge of every terminology is required to
propagate all the necessary changes throughout the mappings.
For example, suppose we have pair-wise mappings between COSTAR
Directory, the MDD, NDDF Plus, and RxNorm. If a change is made in
COSTAR, three mappings are affected (COSTAR-MDD, COSTAR-NDDF Plus,
and COSTAR-RxNorm), and knowledge is required of all four terminologies.
A better solution to connecting multiple terminologies to each other is to
choose one terminology as a standard, and mapping all other terminologies
to the one standard. For best results, the standard terminology chosen
should be the most complete and consistent, be free and accessible to
everyone, and have the broadest knowledge base for decision support. Of
course, no terminology is best in all environment (which is why multiple
terminologies exist in the first place), and one needs to choose the
terminology with the combination of features that best serves the purpose of
being a standard, even if these features would not be ideal for any particular
environment.
Suppose we choose NDDF Plus to be the standard and create two-way
COSTAR-NDDF Plus, MDD-NDDF Plus, and RxNorm-NDDF Plus mappings. We
still need pair-wise knowledge to create and maintain the mappings, but we
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only need 4 types of mapping knowledge (COSTAR-NDDF Plus, MDD-NDDF
Plus, and RxNorm-NDDF Plus) instead of 6.
Furthermore, maintenance is simplified. When a change is made in COSTAR
Directory, only the COSTAR-NDDF Plus mapping needs to be examined and
modified. Because COSTAR is not directly linked to the MDD or RxNorm,
users of the latter two terminologies can remain blissfully ignorant of the
change in COSTAR.
In this system, translating a COSTAR concept to an MDD concept would
require two translations. The COSTAR concept is first translated to an NDDF
Plus concept, and then the NDDF Plus concept is translated to an MDD
concept. Translating twice may introduce more errors than a direct mapping
between COSTAR and MDD, but this is the price of keeping the problem of
universal translation between medication terminologies tractable.
Note that changes in the standard terminology will need to be propagated to
each mapper responsible for maintaining the mapping between the standard
terminology and the local terminology. If there is a change in NDDF Plus, for
example, mappings between NDDF Plus and each of the other terminologies
will need to be examined and modified as needed.
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MEDICATION RECONCILIATION
Adverse drug reactions (ADRs) represent an important clinical issue. It has
been estimated that in 1994, 2,216,000 hospitalized patients had serious
ADRs and 106,000 had fatal ADRs, making these reactions between the
fourth and sixth leading cause of death.2 2
The Joint Commission on Accreditation of Healthcare Organizations (CAHO)
has a sentinel even database that includes more than 350 medication errors
resulting in death or major injury.23 Of those, 63 percent related, at least in
part, to breakdowns in communication, and approximately half of those
would have been avoided through effective medication reconciliation.
Medication reconciliation is the process of comparing a patient's medication
orders to all of the medications that a patient has been taking. This is done
to avoid medications errors such as omissions, duplications, dosing errors, or
drug-drug interactions. One obstacle to medication reconciliation is the
fragmentation of care among different providers, especially if they use
different EMRs. However, medication reconciliation is important even when
only one EMR is used in the care of the patient.
Medication List Accuracy
A study done in 1996 at a geriatric center about the accuracy of medication
data in an outpatient electronic medical record highlights the importance of
medication reconciliation.2 4 Accuracy depends on how strict one wants to be,
and the gold standard is real-time confirmation of the medications with the
patient.
For medications that were on the EMR's list of active medications,
* 83% had the correct compound, dose, and schedule
* 92% had the correct compound from the clinician perspective (ignoring
dose and schedule)
* 90% had the correct compound from the computer (decision support)
perspective (must be in encoded in the controlled medication
terminology)
22 Lazarou , Pomaranz BH, Corey PN. Incidence of Adverse Drug Reactions in
Hospitalized Patients. JAMA. 1998;279:1200-1205.
23 Joint Commission on Accreditation of Healthcare Organizations, Sentinel Event
Alert, Issue 35, January 23, 2006.
24 Wagner WM, Hogan WR. The accuracy of medication data in an outpatient
electronic medical record. JAMIA. 1996; 3(3): 234-244.
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For each list, there was an average of
0.37 missing medications from the clinician perspective
1.38 missing medications from the computer (decision support)
perspective
Types of error included the following:
· 27.8% extra medication listed
* 27.2% missing medication
· 34.8% inaccurate dose or schedule
· 10.1% other
Sources of error included the following:
* 36.1% patient-initiated changes
* 21.5% medical center specialists without EMR write privilege
* 13.3% handwritten orders not entered into the EMR
* 8.9% the clinic MD
* 8.2% data entry error
* 7.6% unknown
* 4.4% an outside MD
Given that much of the error (36.1%) comes from patient-initiated changes,
medication reconciliation is always necessary at every encounter. Even if
one records a perfectly accurate medication list at the end of an encounter
and has access to changes to made by other providers, the list can only be
expected to be about 96% accurate (in terms of compound/dose/schedule)
by the next encounter, at best. The successful implementation of patient
portals may improve the situation in the future by allowing patients to update
their medication lists with changes they themselves initiate.
JCAHO Requirements for Medication Reconciliation
In July 2004, the JCAHO announced 2005 National Patient Safety Goal #8 to
"accurately and completely reconcile medications across the continuum of
care." Accredited healthcare organizations were required to develop and test
processes for medication reconciliation and implement them by January 2006.
The updated requirements for 2006 are as follows:
(8a) Implement a process for obtaining and documenting a complete list of
the patient's current medications upon the patient's admission to the
organization and with the involvement of the patient. This process includes a
comparison of the medications the organization provides to those on the list.
(8b) A complete list of the patient's medications is communicated to the next
provider of service when a patient is referred or transferred to another setting,
service, practitioner or level of care within or outside the organization.
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The implementation expectations for requirement (8b) state that at a
minimum, reconciliation must occur any time the organization requires that
orders be rewritten and any time the patient changes service, setting,
provider or level of care and new medication orders are written. Because the
scope of Goal #8 includes the entire continuum of care, it applies to
ambulatory, emergency, urgent care, long term care, and home care settings
as well as inpatient services.
Role of EMRs in Medication Reconciliation
The process of medication reconciliation often requires three different
medication lists: the original medication list, the current medication list, and
the discharge medication list. Building these lists manually is a time-
consuming process, and the EMR should assist in this process if at all
possible.
If all the settings of care share a single EMR, then building these lists and
communicating these lists between settings is simplified. If medications in
the EMR are encoded as a controlled terminology, then decision support
could be implemented to check for omissions, duplications, dosing errors, or
drug-drug interactions.
Building medication lists is more difficult when patients move between
settings that do not use the same EMR. To assist in building the original
medication list for medication reconciliation, the EMR at the new setting will
need to import medication lists from all other settings, merge the multiple
lists into one list, and then allow the transfer of medications on this merged
list into orders and the use of this list as the basis for the discharge list.
Importing medication lists from other EMRs is only possible if the other EMRs
provide standard services for exporting medication lists and the EMRs agree
on a standard for medication lists and medication records. Merging
medication lists requires either a standard medication terminology or a
reasonably good mappings between the various terminologies, so that it is
possible to tell which medication records refer to the same medications.
When the medication lists have been merged and re-encoded using the local
controlled medication terminology, local decision support can come into play.
Finally, when the patient leaves the current setting, the original list and the
current list are reviewed and a discharge list is constructed and recorded.
This discharge list is communicated to the patient and should be available to
other EMRs through the same standard services already mentioned.
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SUMMARY
Medications are an integral part of healthcare and they must be implemented
carefully and rationally in EMRs.
Controlled medication terminologies are essential for decision support, but
they are not trivial to build. There is no general agreement on what
medication concepts should be because medication concepts at different
levels of granularity serve different purposes. The ideal terminology can
accommodate concepts at multiple levels of granularity in a consistent
fashion. However, the number of levels should be restricted to keep the
terminology from exploding beyond a manageable size.
Many different medication terminologies exist because different sets of
providers of healthcare have different needs. It is too much to expect a
common medication terminology to serve everyone's need. However, for the
sake of communication, translation services are necessary. Translation will
not be perfect and some information will be lost, but essential information
should get through. To keep the problem tractable, it is better to choose a
single common terminology for all translation services to go through than to
create mappings between every pair of terminologies.
While medication terminologies form a foundation in EMRs, attention must
also be given to the implementation of medication records and medication
lists. Well-implemented medication records make it easy to navigate the
patient's medication history. A good implementation of medication lists
distinguishes between descriptive and prescriptive medication lists.
Finally, it is not enough to be able to translate concepts in one terminology to
another. EMRs need to be able to communicate medication records and
medication lists with each other as well. Standards need to be developed for
the communication of medication records and medication lists.
Adverse drug reactions are a major problem in healthcare. EMRs that
provide medication decision support and assist in medication reconciliation
are expected to play a large role in solving this problem.
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